Jay David Caplan - 12 Sep 2024 Form 4 Insider Report for FRACTYL HEALTH, INC. (GUTS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Sep 2024, 18:39:14 UTC
Prior SEC filing
08 Feb 2024
Next SEC filing
13 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lisa A. Davidson, Attorney-in-fact

Key filing fact

Jay David Caplan filed Form 4 for FRACTYL HEALTH, INC. (GUTS) on 13 Sep 2024.

Key facts

  • This page summarizes Jay David Caplan's Form 4 filing for FRACTYL HEALTH, INC. (GUTS).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 Sep 2024, 18:39.

Change

  • Previous filing in this sequence was filed on 08 Feb 2024.
  • Current net transaction value: -$26,151.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GUTS transaction

Common Stock

Options Exercise

Transaction value
$162,323
Shares
+95,484
Change %
Price
$1.70
Shares after
95,484
Date
12 Sep 2024
Ownership
Direct
GUTS transaction

Common Stock

Sale

Transaction value
$188,474
Shares
-65,000
Change %
-68%
Price
$2.90
Shares after
30,484
Date
12 Sep 2024
Ownership
Direct
Footnotes
F1
GUTS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
358,806
Date
12 Sep 2024
Ownership
By Trust
GUTS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
118,810
Date
12 Sep 2024
Ownership
By Family Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GUTS transaction Derivative

Stock Option

Options Exercise

Transaction value
$0
Shares
-95,484
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Sep 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
95,484
Exercise price
$1.70
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $2.85 to $3.06. The Reporting Person undertakes to provide upon request the Staff of the Securities and Exchange Commission, the Issuer, or any stockholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Footnote F2

The option is fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .